There are tests to detect cognitive impairment in multiple sclerosis.
Combined administration of 2 sections of the Brief International Cognitive Assessment for multiple sclerosis (BICAMS), the symbol digit modalities test (SDMT), and brief visuospatial memory test-revised (BVMT-R), reliably detects cognitive impairment in patients with multiple sclerosis (MS) in a more time-efficient manner than administering the whole BICAMS, according to findings presented at the 7th Joint ECTRIMS-ACTRIMS Meeting, held October 25-28, 2017 in Paris.
“The screening tool [BICAMS] was proposed as an international instrument to homogenize cognitive assessment across countries,” the researchers wrote. With its 20-[minute] application time, it is one of the few tools available to be implemented even in small [centers] with only [a] few staff members who might not be particularly trained in administering neuropsychological tests.”
When applying the full BICAMS battery, 41.7% of screened patients had cognitive impairment. The combined SDMT and BVMT-R tests (93.0%, P =.002) and the VLMT and BVMT-R (93.6%, P<.001) had a significantly higher consistency with the total BICAMS battery compared with the combined SDMT and VLMT tests (89.5%). All combinations of two tests were more consistent with the full BICAMS battery than single tests alone.
Read full article: Detecting Cognitive Decline in Multiple Sclerosis With Shortened BICAMS
|Read Full Article: Detecting Cognitive Decline in Multiple Sclerosis With Shortened BICAMS|